Table A1.9Survival data for second- and third-line treatment (in months)

InterventionSourceTTP - respondersTTP - stableTTP - progression
T2 and T3: VINMartin et al. 20075.775.771.13
T2 and T3: CAPPierga et al. 200312.89.523.45

From: Appendix 1, A cost-utility analysis of chemotherapy sequences for the treatment of patients with advanced breast cancer

Cover of Advanced Breast Cancer
Advanced Breast Cancer: Diagnosis and Treatment.
NICE Clinical Guidelines, No. 81.
National Collaborating Centre for Cancer (UK).
Copyright © 2009, National Collaborating Centre for Cancer.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licenses issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.